精品亚洲a∨无码专区毛片-精品亚洲aⅴ无码午夜在线-精品亚洲aⅴ无码午夜在线观看-精品亚洲aⅴ无码一区二区三区-精品亚洲aⅴ无码专区毛片-精品亚洲aⅴ在线

產(chǎn)品展廳收藏該商鋪

您好 登錄 注冊(cè)

當(dāng)前位置:
蘇州螞蟻淘生物科技有限公司>供求商機(jī)>MatriksBiotek品牌產(chǎn)品列表介紹
MatriksBiotek品牌產(chǎn)品列表介紹
返回列表頁
  • MatriksBiotek品牌產(chǎn)品列表介紹

舉報(bào)
貨物所在地: 江蘇蘇州市
更新時(shí)間: 2024-08-01 21:00:06
期: 2024年8月1日--2025年2月1日
已獲點(diǎn)擊: 736
在線詢價(jià)收藏產(chǎn)品

(聯(lián)系我們,請(qǐng)說明是在 化工儀器網(wǎng) 上看到的信息,謝謝!)

產(chǎn)品簡(jiǎn)介

MatriksBiotek品牌產(chǎn)品列表介紹
MatrikSBIotek®Co。,作為一家成立于2002年的生物技術(shù)公司,正在慶祝其15年的業(yè)務(wù)。 以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫,分子和工具,將有助于健康。 在市場(chǎng)上使用生物藥物測(cè)試SHIKARI®ELISA試劑盒,自從在市場(chǎng)上*生產(chǎn)和商業(yè)化以來已有10年的歷史。

詳細(xì)介紹

MatriksBiotek品牌產(chǎn)品列表介紹


MatrikSBIotek®Co。,作為一家成立于2002年的生物技術(shù)公司,正在慶祝其15年的業(yè)務(wù)。 以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫,分子和工具,將有助于健康。 在市場(chǎng)上使用生物藥物測(cè)試SHIKARI®ELISA試劑盒,自從在市場(chǎng)上*生產(chǎn)和商業(yè)化以來已有10年的歷史。 

在36個(gè)國家和30多家制藥公司充滿信心地使用和/或使用我們的產(chǎn)品。 生物制劑(主要是人源化重組單克隆抗體)在某些疾病中作為藥物的使用引起每個(gè)單獨(dú)治療的人的有效性問題。 監(jiān)測(cè)藥物水平和抗體在管理對(duì)重組和/或人源化抗體的反應(yīng)缺乏或喪失方面發(fā)揮著新的作用(即,確認(rèn)治療持續(xù),劑量調(diào)整,提供轉(zhuǎn)換為另一種藥劑或不同藥劑的理由 一類生物制劑)。

 

MatriksBiotek品牌產(chǎn)品列表介紹

 

MatrikSBIotek介紹

Reference CodeProduct NameDescription
TR-Q-INFLIXIv2Q-INFLIXIEnzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma
TR-ATIv5Q-ATIEnzyme immunoassay for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv6Q-ATIEnzyme immunoassay for the quantitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv8Q-ATI DUOEnzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma.
TR-ADAv1Q-ADAEnzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma
TR-AADAv1S-ATAEnzyme immunoassay for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv2S-ATAEnzyme immunoassay for the quantitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv4S-ATA DUOEnzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma
TR-ETAv2Q-ETAEnzyme immunoassay for the quantitative determination of free Etanercept (Enbrel) in serum and plasma
TR-AETAv2S-ATEEnzyme immunoassay for the qualitative determination of antibodies to etanercept in serum and plasma
TR-BEVAv2Q-BEVAEnzyme immunoassay for the quantitative determination of Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv1S-ATBEnzyme immunoassay for the qualitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv2S-ATBEnzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-RTXv2Q-RITUXEnzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv1S-ATREnzyme immunoassay for the qualitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv2S-ATREnzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-TRASv2Q-TRASEnzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®)
TR-ATRASv1S-ATTEnzyme immunoassay for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-ATRASv2S-ATTEnzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-GOLv1Q-GOLEnzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma.
TR-ATGv1S-ATGEnzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma.
TR-CETv1Q-CETEnzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma.
TR-ATCv1S-ATCEnzyme immunoassay for the qualitative determination of antibodies to cetuximab in serum and plasma.
TR-ATCv2S-ATCEnzyme immunoassay for the quantitative determination of antibodies to cetuximab in serum and plasma.
TR-REMSv1Q-REMSEnzyme immunoassay for the quantitative determination of free Infliximab (Remsima®) in serum and plasma.
TR-AREMSv1S-AIREnzyme immunoassay for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma.
TR-AREMSv2S-AIREnzyme immunoassay for the quantitative determination of antibodies to Infliximab Remsima in serum and plasma.
TR-AREMSv3S-AIREnzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma.
TR-QDENv1Q-DENEnzyme immunoassay for the quantitative determination of Denosumab (Prolia®)in serum and plasma.
TR-AATDv1S-ATDEnzyme immunoassay for the qualitative determination of antibodies to Denosumab in serum and plasma.
TR-OMAv1Q-OMAEnzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) Remsima in serum and plasma.
TR-AATOv1S-ATOEnzyme immunoassay for the qualitative determination of antibodies to Omalizumab in serum and plasma.
TR-Q-NIVOv1Q-NIVOEnzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma.
TR-ATNv1S-ATNEnzyme immunoassay for the qualitative determination of antibodies to Nivolumab in serum and plasma.
TR-PEMv1Q-PEMEnzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma.
TR-A-PEMv1S-ATPEnzyme immunoassay for the qualitative determination of antibodies to Pembrolizumab in serum and plasma.
TR-AFAv1Q-AFAEnzyme immunoassay for the quantitative determination of specific anibodies to Filgrastim in serum and plasma.
TR-IPIv1Q-IPIEnzyme immunoassay for the quantitative determination of specific Ipilimumab(Yervoy®) in human serum and plasma.
TR-AIPIv1S-ATIEnzyme immunoassay for the qualitative determination of specific anibodies to Ipilimumab in serum and plasma.
TR-Q-AVEv1Q-AVEEnzyme immunoassay for the quantitative determination of specific Avelumab(Bavencio®) in human serum and plasma.
TR-A-AVEv1S-ATAVEnzyme immunoassay for the qualitative determination of specific anibodies to Avelumab in serum and plasma.
TR-RANv1Q-RANEnzyme immunoassay for the quantitative determination of free Ranibizumab in aqueous humour.
TR-RAMv1Q-RAMEnzyme immunoassay for the quantitative determination of free Ramucirumab in serum and plasma.
TR-ARAMv1S-ATRAMEnzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma.
TR-CERTv2Q-CERTEnzyme immunoassay for the quantitative determination of Certolizumab in human serum and plasma
TR-Q-VEDOv1Q-VEDOEnzyme immunoassay for the quantitative determination of Vedolizumab in human serum and plasma
TR-ATVv1S-ATVEnzyme immunoassay for the qualitative determination of antibodies to Vedolizumab in human serum and plasma
TR-Q-USTv1Q-USTEnzyme immunoassay for the quantitative determination of Ustekinumab in human serum and plasma
TR-AUSTv1S-ATUEnzyme immunoassay for the qualitative determination of antibodies to Ustekinumab in human serum and plasma
 

收藏該商鋪

請(qǐng) 登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~

對(duì)比框

產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 聯(lián)系電話 二維碼 意見反饋 在線交流

掃一掃訪問手機(jī)商鋪
18915418616
在線留言
主站蜘蛛池模板: 国内揄拍国产精品人妻门事件 | 欧美日韩国产中文字幕| 国产精品久久毛片| 人妻精品国产一区二区| 日韩精品一区二区三区中文版 | a级视频不卡无遮挡| 国产中文在线观看| 欧美国产成人精品一区二区三区 | www.日本精品| 天天综合色天天综合网| 精品无人区一区二区三区的特点| 18禁网站免费无遮挡无码中文| 免费av网站不卡在线播放的| 韩国青草视频| 久久9999国产精品免费| 亚洲国产精品一区二区制服| 国产日韩欧美集合一区二区三区| 丁香花视频在线播放免费观看| 日韩欧无码一区二区三区免费不卡 | 91无码人妻一区二区成人aⅴ| 久久99老妇伦国产熟女高清| 精品国产成人三级在线观看| 波多野结衣家教老师| 色综合亚洲一区二区小说| 国产福利小视频尤物98| 永久免费观看美女视频| 日产精品乱码卡一卡2卡三| 国产按摩无码在线观看| 久久综合亚洲精品一区二区| 欧美日韩国产手机在线| 18国产精品白浆在线观看免费 | 国产无遮挡又黄又爽免费网站| 亚洲精品乱码8久久久久久日本| 日本无码免费AAAAAA片| 大帝av在线一区二区三区| 国产精品人妻一区二区三区无码| 六月婷婷激情| 2024国产综合在线| 无码人妻精品中文字幕手机版| 国产疯狂xxxⅹ乱大交| 97亚洲狠狠色综合久久位|